Publication | Closed Access

Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndrome

GynecologyPolycystic Ovary SyndromeObesityThrombosisMetabolic SyndromeHematologyBleeding DisorderAtherosclerosisHealth SciencesFibrinolysisVascular BiologyEndocrinologyOvarian HormoneCardiovascular DiseasePhysiologyHemostasisCoagulopathyMedicineYoung Obese WomenWomen's Health